Scientists test powerful, targeted radiation to fight tough lung cancers
NCT ID NCT01770418
Summary
This study is testing whether a shorter, more intense course of proton radiation therapy, given alongside standard chemotherapy, is safe and effective for people with stage II or III non-small cell lung cancer. Proton therapy is a precise type of radiation that aims to better target tumors while sparing healthy tissue. The goal is to see if this approach can better control the cancer and improve survival compared to standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hampton University Proton Therapy Institute
Hampton, Virginia, 23666, United States
-
Maryland Proton Treatment Center
Baltimore, Maryland, 21201, United States
-
Northwestern Medicine Chicago Proton Center
Warrenville, Illinois, 60555, United States
-
Oklahoma Proton Center
Oklahoma City, Oklahoma, 73142, United States
-
Princeton ProCure Management LLC
Somerset, New Jersey, 08873, United States
-
University of Florida Proton Therapy Institute
Jacksonville, Florida, 32206, United States
Conditions
Explore the condition pages connected to this study.